Recent Articles
Is Echo IQ (ASX:EIQ) a Buy? Mayo Clinic Deal and ASX Index Entry Signal a Major Turning Point
Echo IQ (ASX:EIQ) is surging…
Is Myer (ASX:MYR) a Buy After Profit Jumps 33%? The Margin Story Tells a Different Tale
Myer (ASX:MYR) jumped 7% on…
Oil Crashes 11% on Trump’s Iran Pause: Should You Sell Woodside and Santos Now?
Oil Crashes 11%: Sell Woodside…
ASX Lithium Stocks Jump as China Futures Surge 6%: Is It Finally Time to Buy?
ASX Lithium Stocks Surge After…
Oil Drops 10% as Trump Blinks, But the War Risk Isn’t Gone
The Market Prices a Pause,…
Clover Corporation (ASX:CLV) Surges 18% as Margins Explode on a Europe-Led Mix Shift
The Business Model Upgrade Is…
Is it time to be greedy in the stock market with gold selling off
It has been a very…
DorsaVi (ASX:DVL) V6.5 Upgrade Pushes Intelligence Onto the Sensor
Upgrades FDA-Cleared Sensors, No Device…
Lark Distilling Company (ASX: LRK) Growth is coming through, but the market is still waiting for proof of conversion
Lark Distilling has spent the…
The final building block for Eco-Clay’s rollout is here thanks to a deal between Green360 Technologies (ASX:GT3) and Calix (ASX:CXL)!
The potential of Green360 Technologies‘…
Biome Australia (ASX:BIO): Strong fundamentals are not enough, when the chart is breaking down
Strong fundamentals are not enough…
Brett Blundy buying into weakness as Lovisa’s chart tests conviction
Brett Blundy has always been…
Murray Cod Australia (ASX: MCA) Scaling is working, but the market is still waiting for cash
Scaling is working, but the…
Synlait (ASX:SM1): You Can’t Fault Management’s Honesty, But Can You Have Hope?
There is a particular kind…
Is the Iran war worse than COVID? Here’s why it could be, and how a worst case scenario can be avoided
Imagine this time 6 years…
Tesla (NASDAQ:TSLA) Just Announced Terafab, A US$25B Chip Moonshot
Tesla (TSLA) Just Picked the…
Amplia (ASX:ATX) Surges 80% After Rare Pancreatic Cancer Responses
Survival Up 2.6 Months, AACR…
Stagflation Risk Is Back, The 1970s Show Why It Matters
The 1970s Aren’t a Forecast,…
ASX 200 Hits Correction, Bonds Spike, The Oil Shock Is Spreading
This Isn’t Just Geopolitics Anymore,…
Should You Buy Ampol Shares Amidst the Iran War?
Investors looking for somewhere, anywhere,…
Find Us in
Stocks Down Under Analysts delve into a large variety of ASX-listed stocks and sectors.
Sector Analysis
The Best Mining Stocks
Mining and resources stocks have substantial potential given demand for all types of resources and metals from gold and iron ore to battery metals like lithium and graphite! There are over 700 stocks in this sector from big miners to small cap explorers.
The Best Tech Stocks
Tech stocks are appetising in the context of an increasingly digital world ranging from data centre builders, cloud services providers and cybersecurity companies. Many of the ASX's best performing stocks in the last decade have been tech stocks.
The Best Uranium Stocks
Uranium stocks are in a good spot right now with rising demand for clean energy, nuclear energy making a comeback and yellowcake pricing reaching levels not seen since the GFC. This has enabled many companies with mothballed projects to bring them out of hibernation.
The Best Healthcare Stocks
There are dozens of Healthcare stocks on the ASX ranging from big names like CSL and Cochlear with established products and markets, to small cap biotechs and medtechs hoping to follow in their footsteps and commercialise the next big innovation.
The Best Mining Stocks
The Best Tech Stocks
The Best Uranium Stocks
Share Type Analysis
The Best ASX Stocks Right Now
The quest for the best stocks to buy now is a never-ending one, but armed with a solid investment strategy, you can create a diversified portfolio that stands the test of time. We provide our Top 10 ASX stocks we think investors should consider right now.
The Best ASX Stocks Right Now
The Top Penny Stocks
Navigating ASX Penny stocks, can be complex, given the diversity of companies operating in various sectors and the high risk associated with them. But there is potential for impressive returns if investors can find the right company.
The Top Penny Stocks
The Top Dividend Stocks
Investing in Dividend stocks can provide an additional source of income, and so are popular with a wide variety of investors. But only some companies pay dividends, and even consistent payers can fluctuate payouts year to year. We outline the Top Dividend Stocks for investors to consider.
The Top Dividend Stocks
Top ASX Index Funds
Explore our comprehensive analysis of the top ASX index funds, carefully curated by industry experts. Discover which funds are currently outperforming and why, based on detailed market trends and performance metrics. Ideal for both new and seasoned investors seeking strategic investment opportunities on the ASX. Dive into our report today to make informed investment decisions.
Top ASX Index Funds
The Top Blue Chip Stocks
Discover the best ASX blue chip stocks for investment. Our industry experts provide in-depth analysis on these well-established companies with strong credit ratings and a long history of performance and stability. Explore market leaders like Commonwealth Bank of Australia, BHP Group Ltd, and National Australia Bank Limited.
The Top Blue Chip Stocks
Top ASX Growth Stocks for Investing
Explore our comprehensive analysis of the top ASX growth stocks for investing. Our industry experts have curated a detailed report on the most promising opportunities available in the market. Whether you're a seasoned investor or just starting out, our insights provide valuable information to help you make informed decisions.
Top ASX Growth Stocks for Investing
Webinars and Interviews
Rhythm Biosciences (ASX:RHY) is now cleared to offer its ColoSTAT test to patients in Australia!
Rhythm Biosciences (ASX:RHY) We spoke to Dr David Atkins, CEO of Rhythm Biosciences (ASX:RHY), about the…
Upside Gold (CSE:UG) has a sizable 3.3m oz gold resource to get excited about
Upside Gold (CSE:UG) We talked with Sophie Cesar, CEO of Upside Gold (CSE:UG), about the large…
Australis Oil and Gas (ASX:ATS) to develop the Tuscaloosa Marine Shale
Australis Oil and Gas (ASX: ATS) We spoke with Ian Lusted, Managing Director of Australis Oil…
BCAL Diagnostics (ASX: BDX): Interview with Executive Chair Jayne Shaw
BCAL Diagnostics (ASX: BDX) We spoke to Jayne Shaw, Executive Chair of BCAL Diagnostics (ASX: BDX)…
Investment Glossary
What Is a Small Cap Company? A Complete Guide for Investors
Overview of Small Cap Companies…
What is the All Ordinaries Index and How Does It Work?
The All Ordinaries Index, also…
What is Commodity? Understanding Commodity Trading
Introduction to Commodities Commodities are…
Overview of Securities in the Australian Financial Market
What is a security? Security refers…
What Is an IPO? Understanding Initial Public Offerings
What is IPO? An Initial Public…
The Team Behind Stocks Down Under
Stuart Roberts
Co-Founder
Stuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research
Marc Kennis
Co-Founder
Marc is the co-founder of Stocks Down Under and has 25+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research,
The Team Behind Stocks Down Under
STUART ROBERTSStuart Roberts is the co-founder of Stocks Down Under. Previously, Stuart covered the healthcare and biotechnology sectors at NDF Research and at stockbroking firms Southern Cross Equities, Bell Potter and Baillieu Holst from 2002 to 2015, where he developed a reputation for detailed analysis on previously uncovered Life Science companies. In 2018, he co-founded Pitt Street Research together with Marc.
MARC KENNISMarc is the co-founder of Stocks Down Under and has 20+ years experience analyzing companies in a range of sectors, including Food & Beverage, Industrials, Technology, Medical Equipment, Telecom and Media. Prior to moving to Australia in 2014, he worked for a number of brokers and banks in The Netherlands, including ING and Rabobank. In 2018, Marc co-founded Pitt Street Research, Australia's preeminent issuer-sponsored equities research firm.
PETER KILBYPete is Stocks Down Under's head of customer service. He is an avid investor with a knack for deep-dive company research. Pete likes the more established companies on ASX, but doesn't shy away from the occasional risky play. At Stocks Down Under he gets to do the two things he loves most, investing and talking to like-minded people.
Get in touch
contact@stocksdownunder.com
Follow us on